The very elderly males with Paget’s
disease, rheumatoid arthritis, multiple myeloma, primary hyperparathyroidism,
thyrotoxicosis, chronic renal failure, or thosereceiving bone-active drugs (corticosteroids, bisphosphonates, denosumab, raloxifene, teriparatide, etc.)